Search Results for:

Sabinsa’s intellectual property portfolio now includes 308 separate patents granted across the world. The most recent patents granted include several from Australia, Canada, Europe, and the USA. Sabinsa’s patent portfolio includes composition, use and process patents. Many are for various aspects of category leader ingredients such as LactoSpore®, DigeZyme® and Curcumin C3 Complex®; others are … Read more

Sabinsa’s flagship combination product, Curcumin C3 Complex® with BioPerine® (525mg/2.5 mg twice a day, 14 days), was used as adjuvant therapy for COVID-19 in a double-blind, randomized controlled clinical trial conducted on COVID-19 patients in India, where the wide-spread virus infection has strained the healthcare system. The trial involved a total of 140 patients with … Read more

Sami-Sabinsa Group Limited, the world leader in Curcumin for the dietary supplements industry, has been awarded more than $1 Million in attorney’s fees and costs against Prakruti Products. The award, issued by a federal judge in New Jersey on May 24, came in the wake of Sabinsa’s successful prosecution of Prakruti’s egregious discovery misconduct. The … Read more

Dr. Muhammed Majeed, founder of the Sami-Sabinsa Group, was named the Father of Indian Nutraceuticals Industry with an honorary award presented on the occasion of ASSOCHAM’s virtual conference entitled Efficacy of Herbal Nutraceuticals: Stimulating the New Lifestyle. The Associated Chambers of Commerce and Industry of India (ASSOCHAM) is an organization of over 300 Chambers of … Read more

A study on an oil control moisturize developed by Sami / Sabinsa was recently published; An open label clinical study to evaluate the dermal safety ad post-application effect of an oil control moisturizer appeared in the European Journal of Biomedical and Pharmaceutical Sciences (ejbps), 2016, Volume 3, Issue 10, 462-466. The efficacy and safety of an oil control … Read more

A study evaluating the effects of Sabinsa’s Boswellin® Super (BSR) on knee pain reduction was recently published in the European Journal of Biomedical and Pharmaceutical Sciences (2016, Volume 3, Issue 10, 293-298): The Effect of Boswellin Super on Knee Pain in Japanese Adults: A randomized, double-blind, placebo-controlled trial. Boswellin® Super (BSR), a standardized extract from the gum resin … Read more

Sabinsa Corp. has again prevailed in legal action protecting one of the company’s patent, this time in a law suit filed against Aegle Bios Inc. (Edison, NJ) for willful patent infringement on June 8, 2016. On November 7, 2016 the United States District Court for the District of New Jersey, in a written Order, held: … Read more

Sabinsa’s Vice President of Scientific Affairs, Anurag Pande PhD, will moderate and speak on a panel at the 6th China International Nutraceutical and Functional Food Summit 2016, held on November 15th–17th2016 in Beijing Crowne Plaza. The Panel Discussion, Market Trends and Innovative Ingredients Applied in Functional Food R&D, will take place on Wednesday November 16th. The three-day summit … Read more

Nachurel Ingredients LLC(North Brunswick, NJ) has agreed to a Final Consent Judgment that resolves a previous lawsuit for infringement of Sabinsa’s U.S. Patent No. 6,653,327, covering compositions and uses of turmeric-derived Tetrahydrocurcuminoids. In the Consent Judgment, the Court found: “It is hereby determined and found that the ’327 Patent is valid, enforceable, and was properly … Read more